- Home
- AQMS vs HCWB Comparison
AQMS vs HCWB Comparison
Compare AQMS & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- HCWB
- Stock Information
- Founded
- AQMS 2014
- HCWB 2018
- Country
- AQMS United States
- HCWB United States
- Employees
- AQMS N/A
- HCWB N/A
- Industry
- AQMS Metal Fabrications
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- HCWB Health Care
- Exchange
- AQMS Nasdaq
- HCWB Nasdaq
- Market Cap
- AQMS 10.3M
- HCWB 8.7M
- IPO Year
- AQMS 2015
- HCWB 2021
- Fundamental
- Price
- AQMS $14.56
- HCWB $3.99
- Analyst Decision
- AQMS Buy
- HCWB Strong Buy
- Analyst Count
- AQMS 1
- HCWB 1
- Target Price
- AQMS $30.00
- HCWB $35.00
- AVG Volume (30 Days)
- AQMS 6.1M
- HCWB 106.2K
- Earning Date
- AQMS 11-13-2025
- HCWB 11-13-2025
- Dividend Yield
- AQMS N/A
- HCWB N/A
- EPS Growth
- AQMS N/A
- HCWB N/A
- EPS
- AQMS N/A
- HCWB N/A
- Revenue
- AQMS N/A
- HCWB $832,841.00
- Revenue This Year
- AQMS N/A
- HCWB $178.64
- Revenue Next Year
- AQMS $550.00
- HCWB N/A
- P/E Ratio
- AQMS N/A
- HCWB N/A
- Revenue Growth
- AQMS N/A
- HCWB N/A
- 52 Week Low
- AQMS $3.37
- HCWB $2.77
- 52 Week High
- AQMS $39.40
- HCWB $100.80
- Technical
- Relative Strength Index (RSI)
- AQMS 57.68
- HCWB 46.48
- Support Level
- AQMS $11.56
- HCWB $4.00
- Resistance Level
- AQMS $39.37
- HCWB $4.55
- Average True Range (ATR)
- AQMS 4.32
- HCWB 0.29
- MACD
- AQMS 0.98
- HCWB 0.01
- Stochastic Oscillator
- AQMS 27.29
- HCWB 27.00
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.